IAS EXPANDS GLOBAL MEASUREMENT OF AMAZON PROPERTIES
Get Alerts IAS Hot Sheet
Join SI Premium – FREE
Advertisers Now Have Access to Expanded Post-Bid Measurement for Campaigns Across Amazon Audiences and Twitch Inventory
"IAS and Amazon Ads share the value of customer obsession, and our global collaboration demonstrates how our companies continue to maximize return on investment for advertisers and are committed to providing independent measurement," said
IAS now provides Amazon DSP media buyers with:
- Brand safety and suitability, viewability, and IVT measurement on custom audiences and Twitch.
- Cross-device measurement for web and in-app across CTV, mobile, desktop, and tablet.
IAS's Brand Safety & Suitability, Viewability, and Invalid Traffic measurement expansion with Amazon Ads will be available in IAS Signal, designed to provide advertisers with greater access to campaign data and a unified view of their global campaigns.
In Q3 2023, IAS enhanced its integration with Amazon Ads to include Context Control pre-bid segments. In addition to IAS's standard pre-bid segments within Amazon DSP, customers can easily have controls to decide where their ads appear and easily reach contextually relevant content.
About Integral Ad Science
Integral Ad Science (IAS) is a leading global media measurement and optimization platform that delivers the industry's most actionable data to drive superior results for the world's largest advertisers, publishers, and media platforms. IAS's software provides comprehensive and enriched data that ensures ads are seen by real people in safe and suitable environments, while improving return on ad spend for advertisers and yield for publishers. Our mission is to be the global benchmark for trust and transparency in digital media quality. For more information, visit integralads.com.
Contact: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/ias-expands-global-measurement-of-amazon-properties-302157428.html
SOURCE Integral Ad Science, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orbis International's Flying Eye Hospital Arrives in Peru to Expand Access to Essential Eye Care
- Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
- The Football Stars Missing This Summer's Cup Receive an Invitation from Ecuador
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share